Inventiva (IVA) Long-Term Investments (2023 - 2025)
Inventiva (IVA) recorded quarterly Long-Term Investments of $613450.9 in Q4 2025, down 99.94% quarter-over-quarter from $945.2 million in Q2 2025, and down 49.6% on a YoY basis from $1.2 million in Q4 2024.
Inventiva (IVA) Long-Term Investments (2023 - 2025) Analysis & Trends
Inventiva's Long-Term Investments history runs 3 years deep, the most recent figure standing at $613450.9 for Q4 2025.
- In Q4 2025, Long-Term Investments fell 49.6% year-over-year to $613450.9; the TTM figure through Dec 2025 stood at $613450.9 (down 49.6% YoY), while the FY2025 annual figure was $613450.9, down 49.6% from the prior year.
- Long-Term Investments was $613450.9 for Q4 2025 at Inventiva, down from $945.2 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $945.2 million in Q2 2025 to a low of $613450.9 in Q4 2025.
- Historically, Long-Term Investments has averaged $190.4 million across 3 years, with a median of $1.5 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Long-Term Investments slipped 20.62% in 2024, then plunged 49.6% in 2025.
- A 3-year view of Long-Term Investments shows it stood at $1.5 million in 2023, then decreased by 20.62% to $1.2 million in 2024, then slumped by 49.6% to $613450.9 in 2025.
- The last three Long-Term Investments figures came in at $613450.9 (Q4 2025), $945.2 million (Q2 2025), and $1.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | 613,450.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 613,450.93 |
| Jun 30, 2025 | 945.19 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Oct 11, 2023 | 3.69 Mn |